March 3rd, 2023
•Here, we present a protocol to evaluate the antibacterial efficacy of an antibiotic-eluting polymer to simulate prophylactic clinical application by using a commercially available real-time ATP-based luminescent microbial viability assay. This method enables the monitoring of the longitudinal activity of drug-eluting materials and can be widely adapted to test anti-microbial drug delivery platforms.
Related Videos
Quantitative Assessment of Immune Cells in the Injured Spinal Cord Tissue by Flow Cytometry: a Novel Use for a Cell Purification Method
Saliva, Salivary Gland, and Hemolymph Collection from Ixodes scapularis Ticks
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
Biomimetic Materials to Characterize Bacteria-host Interactions
Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
A Method to Test the Efficacy of Handwashing for the Removal of Emerging Infectious Pathogens
Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved